Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sexual dysfunction
ICD-10 F13.281 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sexual dysfunction.
F13.281 refers to a condition characterized by a dependence on sedative, hypnotic, or anxiolytic substances, which leads to sexual dysfunction as a direct consequence of substance use. Patients with this diagnosis often exhibit a pattern of compulsive use of these substances, which can include benzodiazepines, barbiturates, and other anxiolytics. The sexual dysfunction may manifest as decreased libido, erectile dysfunction, or other sexual performance issues. This condition not only impacts the patient's sexual health but can also lead to significant interpersonal and psychological distress. The diagnosis requires careful assessment of the patient's substance use history, the severity of dependence, and the specific sexual dysfunction experienced. Treatment typically involves a combination of substance use disorder interventions, including detoxification, counseling, and possibly pharmacotherapy to address both the dependence and the sexual dysfunction. Understanding the interplay between substance use and sexual health is crucial for effective management and recovery.
Detailed psychiatric evaluation and history of substance use, including duration and quantity.
Patients presenting with anxiety disorders who are using benzodiazepines and report sexual dysfunction.
Consideration of other mental health disorders that may contribute to sexual dysfunction.
Assessment of sexual function, including specific tests for erectile dysfunction.
Men presenting with erectile dysfunction who have a history of sedative use.
Need to differentiate between organic and psychogenic causes of sexual dysfunction.
Used for follow-up visits to manage substance dependence and sexual dysfunction.
Document the patient's history, current medications, and sexual health concerns.
Psychiatric evaluations may require additional documentation of mental health status.
Coding F13.281 is crucial for accurately capturing the complexities of substance dependence and its impact on sexual health, which can inform treatment strategies and improve patient outcomes.
